128 related articles for article (PubMed ID: 17929458)
1. [The criteria for avoiding unnecessary computerized tomography and bone scan in staging patients with newly diagnosed prostate cancer: retrospective study of patients at Matsusaka Chuo General Hospital].
Matsumura Y; Otani T; Yoneda T; Matsumoto Y; Maruyama Y; Fujimoto K; Hirao Y
Nihon Hinyokika Gakkai Zasshi; 2007 Sep; 98(6):764-9. PubMed ID: 17929458
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Abdom Imaging; 1996; 21(4):364-7. PubMed ID: 8661585
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
[TBL] [Abstract][Full Text] [Related]
6. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
[TBL] [Abstract][Full Text] [Related]
7. Value of prostate-specific antigen in the staging of Taiwanese patients with newly diagnosed prostate cancer.
Meng E; Sun GH; Wu ST; Chuang FP; Lee SS; Yu DS; Yen CY; Chen HI; Chang SY
Arch Androl; 2003; 49(6):471-4. PubMed ID: 14555332
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of predictors of bone metastasis in prostate cancer cases.
Ho CC; Seong PK; Zainuddin ZM; Abdul Manaf MR; Parameswaran M; Razack AH
Asian Pac J Cancer Prev; 2013; 14(5):3289-92. PubMed ID: 23803117
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
11. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.
O'Sullivan JM; Norman AR; Cook GJ; Fisher C; Dearnaley DP
BJU Int; 2003 Nov; 92(7):685-9. PubMed ID: 14616446
[TBL] [Abstract][Full Text] [Related]
12. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.
Lee N; Newhouse JH; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Malyszko B; Ennis RD
Urology; 1999 Sep; 54(3):490-4. PubMed ID: 10475360
[TBL] [Abstract][Full Text] [Related]
13. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.
Ritenour CW; Abbott JT; Goodman M; Alazraki N; Marshall FF; Issa MM
ScientificWorldJournal; 2009 Oct; 9():1040-5. PubMed ID: 19802499
[TBL] [Abstract][Full Text] [Related]
14. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
[TBL] [Abstract][Full Text] [Related]
15. Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
Abuzallouf S; Dayes I; Lukka H
J Urol; 2004 Jun; 171(6 Pt 1):2122-7. PubMed ID: 15126770
[TBL] [Abstract][Full Text] [Related]
16. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
McArthur C; McLaughlin G; Meddings RN
Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
[TBL] [Abstract][Full Text] [Related]
17. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
Lin K; Szabo Z; Chin BB; Civelek AC
Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
[TBL] [Abstract][Full Text] [Related]
18. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
19. Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
Verburg FA; Pfister D; Heidenreich A; Vogg A; Drude NI; Vöö S; Mottaghy FM; Behrendt FF
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):397-403. PubMed ID: 26563121
[TBL] [Abstract][Full Text] [Related]
20. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.
Lee N; Fawaaz R; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Singh A; Ennis RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1443-6. PubMed ID: 11121646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]